# What Is Semax Peptide Used For? The Research > What is semax peptide used for: the research uses of Semax span neuroprotection in stroke, cognitive support, and mood. A cited, plain-English reading of the literature. From the registered Russian stroke indication to the nootropic reputation — what the studies actually support. ## The short answer If you are asking what is semax peptide used for, the honest answer has two halves. In Russia and Ukraine, where Semax is an approved prescription drug, it is used for ischemic stroke, transient ischemic attack (a brief stroke-like episode), cognitive impairment, and optic-nerve disease [18]. Everywhere else, it is an unscheduled research chemical with no approved use, studied mostly in animals and used informally as a nootropic — a compound taken in the hope of sharper focus and memory. The research backs a brain-protecting effect in rodent stroke models and a rise in brain growth factors [4][1], but the human evidence is thin and mostly Russian. This page reads the use cases against the studies, in plain language, with every figure cited — and it keeps the reported uses separate from the proven ones. ## The registered uses versus the researched uses It helps to separate two categories that get blurred online. The first is what Semax is officially approved for: in Russia and Ukraine it carries registered indications for ischemic stroke, transient ischemic attack, cognitive impairment, and optic-nerve disease, and it sits on Russia's List of Vital and Essential Drugs [18]. That is a real regulatory status — but it is a regional one, not an FDA or EMA approval. The second category is what the wider research has actually measured, which is mostly preclinical: neuroprotection in rodent ischemia [4], neurotrophin upregulation [1][2], monoamine modulation [20], and behavioral-deficit correction in stress models [15]. Informal nootropic use sits in a third, unofficial bucket, supported by mechanism and anecdote rather than trials. Keeping these three apart is the difference between describing the record accurately and overstating it. ## What is semax used for in stroke research The strongest research use is neuroprotection in cerebral ischemia — stroke. Intranasal Semax given for six days in a rat model of focal prefrontal-cortex ischemia reduced the volume of cortical infarction (the size of the dead-tissue zone) and preserved memory on a passive-avoidance task [4]. The protective effect has reproduced at the gene, protein, and inflammation level across cerebral-ischemia and ischemia-reperfusion models [5][9][10][11], with an immune-gene-dominated transcriptional shift identified as a core mechanism [5]. This is also the registered clinical indication in Russia and Ukraine, where Semax sits on the national list of essential drugs [18]. The Western caveat stands: no published randomized controlled trials outside that region [19]. ## Cognitive and nootropic use Semax is classed as a nootropic in Russian pharmaceutical practice, and cognition is what most informal users are after. The mechanistic basis is its rapid, region-specific upregulation of the neurotrophins BDNF and NGF, which support neuron survival, growth, and the synaptic plasticity (the brain's ability to strengthen connections) underlying learning and memory [1][2]. The effect is not a uniform boost: a single 50 microg/kg dose raised some neurotrophin messengers in the hippocampus while lowering NGF messenger in the frontal cortex, a targeted rather than blanket change [2], and the temporal pattern differs across brain regions over hours [13]. In rats, Semax corrected long-lasting behavioral deficits caused by neonatal isolation [15]. Community reports describe quick mental clarity and sustained focus, detailed on the [Semax effects](/effects) page — but a substantial minority report little or no effect, and there are no controlled human cognition trials, so the nootropic use rests on mechanism plus anecdote rather than clinical proof. ## Mood, stress, and other studied uses A third research thread is mood and stress. In human serum in vitro, Semax inhibited enkephalin-degrading enzymes with an IC50 (the concentration giving half-maximal inhibition) of about 10 microM, which would prolong the body's own opioid-peptide signaling — a plausible route to mood and stress effects [3]. In mice it raised the serotonin metabolite 5-HIAA and potentiated amphetamine-evoked dopamine release without raising baseline dopamine on its own [20]. Russia also registered an optic-nerve-disease indication, supported by clinical reports [18]. For a direct comparison with the related anxiolytic peptide, see [Semax vs Selank](/vs-selank). None of these uses is FDA-approved, and none of this is medical advice. ## How it is studied, not how to use it Because "used for" invites a practical question, here is the research framing without crossing into instruction. The doses in the literature are reported per kilogram in animals — for example 50 microg/kg intranasally in rat neurotrophin studies [2] and 0.15 mg/kg by injection in mouse monoaminergic work [20] — and there is no validated human dose outside Russian prescription formulations. The primary studied route is intranasal, which gives the peptide rapid brain access while bypassing first-pass liver metabolism [6]. None of that is a recommendation, a protocol, or a dose anyone should copy; the doses studied and the very short half-life are laid out as research context on the dosing-research page. This site does not tell anyone whether, how, or how much to use — it reports what the studies did. ## What the use cases do not yet have Every use above shares one gap: independent, controlled human confirmation. The deepest evidence — neuroprotection in stroke — is reproduced across rodent transcriptome and proteome studies [9][10][11], but there are no published Western randomized controlled trials [19], and the human work is a handful of older EEG and clinical reports [18]. The neurodegeneration uses people ask about, including Parkinson's and Alzheimer's, rest entirely on animal models. The intact peptide is also cleared from the brain within minutes [6], so any sustained use is leaning on the Pro-Gly-Pro metabolite rather than on Semax itself [8]. None of this erases the findings — it frames them. Semax is a compound with a real, reproducible preclinical record and a thin human one, and that is the accurate answer to what it is used for. --- Filed from the published record on Semax like a front-page dispatch — the rodent neuroprotection and BDNF findings set in plain ink, the Russia-and-Ukraine-only registration and the missing Western trials printed in the same column, with no clinic behind the masthead and nothing here dosed, sourced, or sold.